CUSIP: 15089R102
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,826,225
-
Share change
-
-321,441
-
Total reported value
-
$5,618,140
-
Price per share
-
$1.96
-
Number of holders
-
13
-
Value change
-
-$861,595
-
Number of buys
-
8
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 15089R102?
CUSIP 15089R102 identifies CPXX - CELATOR PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 15089R102:
Institutional Holders of CELATOR PHARMACEUTICALS INC - COM (CPXX) as of Q4 2014
As of 31 Dec 2014,
CELATOR PHARMACEUTICALS INC - COM (CPXX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,826,225 shares.
The largest 10 holders included
CAXTON CORP, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Spark Investment Management LLC, Alpha Cubed Investments, LLC, Concept Capital Markets, LLC, Tower Research Capital LLC (TRC), BlackRock Investment Management, LLC, and DEUTSCHE BANK AG\.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.